Lipid Management in an Era of Evolving Evidence
This activity is supported by educational funding provided by Amgen; Esperion Therapeutics, Inc.; Merck & Co., Inc.; and Novartis Pharmaceuticals Corporation.
Lipid Legends: Key Clinical Challenges in Hypertriglyceridemia (HTG) and the Presentation and Management of Homozygous Familial Hypercholesterolemia
This activity is supported by educational funding provided by Amgen; Arrowhead Pharmaceuticals, Inc.; and Novartis Pharmaceuticals Corporation.
Lipid Legends Podcasts
This activity is supported by educational funding provided by Amgen; Arrowhead Pharmaceuticals, Inc.; and Novartis Pharmaceuticals Corporation.
Lipid Legends: Lipodystrophy Syndromes and Their Treatment Approaches and the Diagnosis and Individualized Treatment of Pediatric Lipid Disorders
This activity is supported by educational funding provided by Amgen; Arrowhead Pharmaceuticals, Inc.; and Novartis Pharmaceuticals Corporation.
Lipid Legends: Reducing Risk Through LDL-C Management and The Role of Lp(a) in Cardiovascular Care and the Role of Lp(a) and Potential Impact of Emerging Therapies
This activity is supported by educational funding provided by Amgen; Arrowhead Pharmaceuticals, Inc.; and Novartis Pharmaceuticals Corporation.